MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-06-2026
Penumbra Total Current Liabilities 2011-2026 | PEN
Annual Total Current Liabilities Penumbra
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 183 M | 158 M | 151 M | 145 M | 123 M | 106 M | 91 M | 66.1 M | 51.6 M | 35.8 M | 28.1 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 183 M | 28.1 M | 104 M |
Total Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
EDAP TMS S.A.
EDAP
|
37.8 M | $ 4.13 | -0.72 % | $ 155 M |  France |
 |
Apyx Medical Corporation
APYX
|
11.7 M | $ 3.67 | 3.09 % | $ 151 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
44.1 M | - | - | $ 1.77 B | USA |
 |
Allied Healthcare Products
AHPI
|
5.98 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.05 M | - | -5.86 % | $ 30.6 M | USA |
 |
Apollo Endosurgery
APEN
|
39.5 M | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
219 M | $ 7.52 | -2.97 % | $ 1.13 B | USA |
 |
Aziyo Biologics
AZYO
|
25.1 M | - | 1.37 % | $ 20.5 M | USA |
 |
Avinger
AVGR
|
19.3 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
65.2 M | - | - | $ 3.31 B | USA |
 |
Helius Medical Technologies
HSDT
|
1.88 M | $ 2.22 | 3.26 % | $ 1.35 M | USA |
 |
BioSig Technologies
BSGM
|
42.8 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
19.7 M | - | -13.19 % | $ 166 K | USA |
 |
OrthoPediatrics Corp.
KIDS
|
46.2 M | $ 17.81 | 1.37 % | $ 418 M | USA |
 |
Conformis
CFMS
|
14.1 M | - | - | $ 16.4 M | USA |
 |
LENSAR
LNSR
|
40.6 M | $ 5.64 | 7.84 % | $ 67.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
10.8 M | $ 12.82 | 9.76 % | $ 363 M | USA |
 |
Cardiovascular Systems
CSII
|
40 M | - | 0.15 % | $ 844 M | USA |
 |
CryoLife, Inc.
CRY
|
60.5 M | - | -4.14 % | $ 702 M | USA |
 |
Cytosorbents Corporation
CTSO
|
9.71 M | $ 0.61 | -0.08 % | $ 38 M | USA |
 |
LivaNova PLC
LIVN
|
808 M | $ 71.86 | 1.32 % | $ 3.92 B |  Britain |
 |
Delcath Systems
DCTH
|
11 M | $ 11.48 | 2.14 % | $ 411 M | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.19 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
18 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Orthofix Medical
OFIX
|
170 M | $ 11.65 | -3.48 % | $ 461 M |  Curacao |
 |
Misonix, Inc.
MSON
|
17.3 M | - | - | $ 462 M | USA |
 |
IRIDEX Corporation
IRIX
|
13.2 M | $ 1.03 | - | $ 17.4 M | USA |
 |
Dynatronics Corporation
DYNT
|
8.24 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
25.3 M | - | - | $ 10.2 M | USA |
 |
Myomo
MYO
|
8.35 M | $ 0.83 | -5.05 % | $ 34.7 M | USA |
 |
Electromed
ELMD
|
10.5 M | $ 26.93 | 0.26 % | $ 228 M | USA |
 |
Butterfly Network
BFLY
|
48.2 M | $ 4.16 | -2.0 % | $ 881 M | USA |
 |
Intersect ENT, Inc.
XENT
|
44.2 M | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
6.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Profound Medical Corp.
PROF
|
6.08 M | $ 6.85 | -4.33 % | $ 207 M |  Canada |
 |
Insulet Corporation
PODD
|
680 M | $ 154.16 | -3.89 % | $ 10.8 B | USA |
 |
GBS
GBS
|
5.35 M | - | -0.57 % | $ 7.12 M | USA |
 |
Sintx Technologies
SINT
|
3.73 M | $ 2.35 | -2.08 % | $ 6.52 M | USA |
 |
Globus Medical
GMED
|
498 M | $ 77.95 | -8.37 % | $ 10.5 B | USA |
 |
CONMED Corporation
CNMD
|
315 M | $ 36.76 | -3.52 % | $ 1.14 B | USA |
 |
Stryker Corporation
SYK
|
7.79 B | $ 285.47 | -2.98 % | $ 109 B | USA |
 |
Inspire Medical Systems
INSP
|
96.1 M | $ 44.26 | -2.87 % | $ 1.3 B | USA |
 |
Integer Holdings Corporation
ITGR
|
232 M | $ 88.12 | 0.23 % | $ 3.06 B | USA |
 |
Invacare Corporation
IVC
|
220 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.81 B | $ 79.96 | -3.44 % | $ 46.8 B | USA |
 |
Tandem Diabetes Care
TNDM
|
243 M | $ 15.48 | -16.19 % | $ 1.05 B | USA |